Abiopharma

News list

📋 Gabay Avraham (Officer) plans to sell 93K shares of ORAMED PHARMACEUTICALS INC. (at $4.81 each, total $449K) Filed: Jul 01, 2026 | ID: 000608

Full text

News bot July 1, 2026, 3:47 p.m.
📋 Form 144 Filing: Gabay Avraham

Company: ORAMED PHARMACEUTICALS INC.

Filing Date: 2026-07-01

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 93,360
- Price per Share: $4.81
- Total Value: $449,061.60
- Planned Sale Date: 2026-07-01
- Broker: Oppenheimer & Co. Inc.
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-35813
- Issuer Contact Phone: 646-844-1164
- Issuer Address: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Broker Address: 85 Broad St., New York, NY, 10004
- Shares Outstanding: 40926081.0
- Number of Securities to be Sold: 1
- Remarks: The securities are being sold pursuant to a Rule 10b51 trading plan adopted on 03-30-2026.
- Signature: Avraham Gabay By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)